Antivirals
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ABACAVIR SULFATE & LAMIVUDINE: products 1 to 7 of 7.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Abacavir-Lamivudine 600mg & 300mg TabDIN 02399539 | General benefit | $5.9875per source unit | Requirements & sourcesBuild cost plan |
| Auro-Abacavir/Lamivudine 600mg & 300mg TabDIN 02454513 | General benefit | $5.9875per source unit | Requirements & sourcesBuild cost plan |
| Jamp Abacavir/Lamivudine 600mg & 300mg TabDIN 02497654 | General benefit | $5.9875per source unit | Requirements & sourcesBuild cost plan |
| Kivexa 600mg & 300mg TabDIN 02269341 | General benefit | $5.9875per source unit | Requirements & sourcesBuild cost plan |
| Mylan-Abacavir-Lamivudine 600mg & 300mg TabDIN 02450682 | General benefit | $5.9875per source unit | Requirements & sourcesBuild cost plan |
| PMS-Abacavir-Lamivudine 600mg & 300mg TabDIN 02458381 | General benefit | $5.9875per source unit | Requirements & sourcesBuild cost plan |
| Teva-Abacavir-Lamivudine 600mg & 300mg TabDIN 02416662 | General benefit | $5.9875per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
08:18 Antivirals.